摘要
良性前列腺增生(BPH)专业防控联盟明确并归纳了常用BPH诊断血清学标志物,如前列腺特异性抗原、前列腺酸性磷酸酶、前2肽前列腺特异抗原及其衍生参数的特性及临床应用情景,经讨论后对常用BPH诊断血清学标志物检测及其注意事项和影响因素形成本共识。
The Alliance for the Prevention and Control of Benign Prostatic Hyperplasia(BPH)has identified and summarized characteristics and clinical application scenarios of widely used BPH diagnostic serological markers,such as prostate specific antigen(PSA),prostate acid phosphatase(PAP),pre 2-peptide prostate specific antigen([-2]proPSA/p2PSA)and their derived parameters.After discussion,BPH has further formed a consensus on the precautions and influencing factors for the detection of the BPH diagnostic serological markers.
出处
《标记免疫分析与临床》
CAS
2023年第8期1261-1265,1315,共6页
Labeled Immunoassays and Clinical Medicine
基金
国家重点研发计划项目(编号:2021YFC2009300,2021YFC2009301)。
关键词
良性前列腺增生
血清学标志物
实验室检测
Benign prostatic hyperplasia
Serological markers
Laboratory testing
